Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Panaxia Labs Israel Ltd
  6. News
  7. Summary
    PNAX   IL0011043630

PANAXIA LABS ISRAEL LTD

(PNAX)
  Report
SummaryChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Panaxia Labs Israel Ltd Reports Earnings Results for the Fourth Quarter and Year 2020

04/05/2021 | 04:34am EDT

Panaxia Labs Israel Ltd. reported earnings results for the fourth quarter and year 2020. For the quarter, the company reported revenue of ILS 17 million compared to ILS 6.7 million a year ago. For the year, the company reported revenue of ILS 60.7 million compared to ILS 16.7 million a year ago. Gross profit in 2020 amounted to ILS 4.2 million, compared to gross losses of ILS 1.9 million in the corresponding period the previous year.


ę S&P Capital IQ 2021
All news about PANAXIA LABS ISRAEL LTD
08/31Panaxia Labs Israel Ltd Reports Earnings Results for the Second Quarter Ended June 30, ..
CI
08/19Panaxia Labs Israel Ltd. and Neuraxpharm Expands Strategic Collaboration to Poland
CI
08/09IM Cannabis Corp.
AQ
04/30IMC Holdings Ltd. agreed to acquire Israel's Largest Retail and Online Pharmacy Busines..
CI
04/12Panaxia Labs Israel Ltd Provides Revenue Guidance for the First Quarter of 2021
CI
04/05Panaxia Labs Israel Ltd Reports Earnings Results for the Fourth Quarter and Year 2020
CI
02/03Government of Cyprus Selects Panaxia Labs Israel Ltd. to Supply Premium Oils
CI
01/28Neuraxpharm France and Panaxia Labs Select the Participation in A Pilot Program for the..
CI
2020Panaxia Labs Israel Ltd Reports Revenue Results for the Third Quarter and Nine Months o..
CI
2020Panaxia Labs Israel Ltd. and Neuraxpharm to Receive A Marketing Permit for Medical Cann..
CI
More news
Financials
Sales 2019 16,7 M 5,22 M 5,22 M
Net income 2019 -81,3 M -25,4 M -25,4 M
Net cash 2019 0,60 M 0,19 M 0,19 M
P/E ratio 2019 -2,85x
Yield 2019 -
Capitalization 215 M 67,3 M 67,3 M
EV / Sales 2018 -
EV / Sales 2019 2,77x
Nbr of Employees -
Free-Float 32,0%
Chart PANAXIA LABS ISRAEL LTD
Duration : Period :
Panaxia Labs Israel Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Dadi Segal Chief Executive Officer & Director
Gil Benyamini Chief Financial Officer
Jonathan B. Kolber Chairman
Eran Goldberg Chief Technology Officer
Tamar Hinenzon Meiri Vice President-Operations
Sector and Competitors
1st jan.Capi. (M$)
PANAXIA LABS ISRAEL LTD-44.48%66
CINTAS CORPORATION21.26%44 319
TELEPERFORMANCE SE31.63%24 357
BUREAU VERITAS SA24.22%14 183
EDENRED SE4.83%14 076
LG CORP.-1.55%12 968